A Kyoto-based startup has developed the world's first cell therapy enabling nerve regeneration using ES/iPS cell-derived Schwann cells. This breakthrough enables large-scale production of cells previously difficult to mass-produce, paving the way for clinical trials.
Leveraging unique technology for creating novel microalgae strains from the environment, we provide microalgae strains useful for industrial and academic applications. Additionally, we offer; 1: consultation on microalgae business plans and experimental designs, 2: guidance on microalgae cultivation techniques, and 3: evaluation of microalgae strains based on growth rate and produced substances. We collaborate with diverse companies—spanning aquaculture, food, semiconductors, chemical materials, pet supplies, and rare metal recovery—as well as universities and research institutions to create new industries that address global challenges.
Millde is a technology-driven company specializing in multi-point Raman spectroscopy and high-sensitivity imaging. It provides non-destructive, label-free analysis of cells, tissues, and materials, primarily through contract research services. Serving regenerative medicine, pharmaceutical, food, and materials industries, Millde delivers high-throughput molecular evaluation. The company also develops and commercializes proprietary multi-point Raman systems and cryogenic Raman technologies, supporting applications from research to industrial implementation.
BIOME, a biodiversity startup spun out of Kyoto University, was founded in May 2017 with the mission of making biodiversity conservation a natural part of society. The company develops and operates the wildlife collection app Biome as a data-gathering tool to build a biodiversity information platform that handles species distribution data from around the world. Data submitted through the app is utilized as foundational biodiversity information and is provided to conservation organizations, research institutions, and other stakeholders in response to their needs.
At Beef Sommelier, we provide our B-som Diagnosis with the aim of creating a world where producers can raise their ideal cattle and consumers can enjoy beef that truly matches their preferences. Our technology not only quantifies biological information from beef cattle, but also supports producers in achieving their target meat quality. By introducing a new scientific perspective that goes beyond conventional standards, we make the “unseen qualities” of beef visible and measurable. This enables consumers to clearly understand the characteristics of the beef they choose. B-som is the world’s first scientific diagnostic service that bridges the gap between producers and consumers.